BACKGROUND: Previous studies have shown that in addition to environmental influences, type 2 diabetes mellitus (T2DM) has a strong genetic component. The goal of the current study is to identify regions of linkage for T2DM in ethnically diverse populations. METHODS: Phenotypic and genotypic data were obtained from African American (AA; total number of individuals [N] = 1004), American Indian (AI; N = 883), European American (EA; N = 537), and Mexican American (MA; N = 1634) individuals from the Family Investigation of Nephropathy and Diabetes. Non-parametric linkage analysis, using an average of 4404 SNPs, was performed in relative pairs affected with T2DM in each ethnic group. In addition, family-based tests were performed to detect association with T2DM. RESULTS: Statistically significant evidence for linkage was observed on chromosome 4q21.1 (LOD = 3.13; genome-wide p = 0.04) in AA. In addition, a total of 11 regions showed suggestive evidence for linkage (estimated at LOD > 1.71), with the highest LOD scores on chromosomes 12q21.31 (LOD = 2.02) and 22q12.3 (LOD = 2.38) in AA, 2p11.1 (LOD = 2.23) in AI, 6p12.3 (LOD = 2.77) in EA, and 13q21.1 (LOD = . 2.24) in MA. While no region overlapped across all ethnic groups, at least five loci showing LOD > 1.71 have been identified in previously published studies. CONCLUSIONS: The results from this study provide evidence for the presence of genes affecting T2DM on chromosomes 4q, 12q, and 22q in AA; 6p in EA; 2p in AI; and 13q in MA. The strong evidence for linkage on chromosome 4q in AA provides important information given the paucity of diabetes genetic studies in this population.
BACKGROUND: Previous studies have shown that in addition to environmental influences, type 2 diabetes mellitus (T2DM) has a strong genetic component. The goal of the current study is to identify regions of linkage for T2DM in ethnically diverse populations. METHODS: Phenotypic and genotypic data were obtained from African American (AA; total number of individuals [N] = 1004), American Indian (AI; N = 883), European American (EA; N = 537), and Mexican American (MA; N = 1634) individuals from the Family Investigation of Nephropathy and Diabetes. Non-parametric linkage analysis, using an average of 4404 SNPs, was performed in relative pairs affected with T2DM in each ethnic group. In addition, family-based tests were performed to detect association with T2DM. RESULTS: Statistically significant evidence for linkage was observed on chromosome 4q21.1 (LOD = 3.13; genome-wide p = 0.04) in AA. In addition, a total of 11 regions showed suggestive evidence for linkage (estimated at LOD > 1.71), with the highest LOD scores on chromosomes 12q21.31 (LOD = 2.02) and 22q12.3 (LOD = 2.38) in AA, 2p11.1 (LOD = 2.23) in AI, 6p12.3 (LOD = 2.77) in EA, and 13q21.1 (LOD = . 2.24) in MA. While no region overlapped across all ethnic groups, at least five loci showing LOD > 1.71 have been identified in previously published studies. CONCLUSIONS: The results from this study provide evidence for the presence of genes affecting T2DM on chromosomes 4q, 12q, and 22q in AA; 6p in EA; 2p in AI; and 13q in MA. The strong evidence for linkage on chromosome 4q in AA provides important information given the paucity of diabetes genetic studies in this population.
Authors: D W Bowden; M Sale; T D Howard; A Qadri; B J Spray; C B Rothschild; G Akots; S S Rich; B I Freedman Journal: Diabetes Date: 1997-05 Impact factor: 9.461
Authors: R E Pratley; D B Thompson; M Prochazka; L Baier; D Mott; E Ravussin; H Sakul; M G Ehm; D K Burns; T Foroud; W T Garvey; R L Hanson; W C Knowler; P H Bennett; C Bogardus Journal: J Clin Invest Date: 1998-04-15 Impact factor: 14.808
Authors: K Yamagata; N Oda; P J Kaisaki; S Menzel; H Furuta; M Vaxillaire; L Southam; R D Cox; G M Lathrop; V V Boriraj; X Chen; N J Cox; Y Oda; H Yano; M M Le Beau; S Yamada; H Nishigori; J Takeda; S S Fajans; A T Hattersley; N Iwasaki; T Hansen; O Pedersen; K S Polonsky; G I Bell Journal: Nature Date: 1996-12-05 Impact factor: 49.962
Authors: M P Stern; R Duggirala; B D Mitchell; L J Reinhart; S Shivakumar; P A Shipman; O C Uresandi; E Benavides; J Blangero; P O'Connell Journal: Genome Res Date: 1996-08 Impact factor: 9.043
Authors: R L Hanson; M G Ehm; D J Pettitt; M Prochazka; D B Thompson; D Timberlake; T Foroud; S Kobes; L Baier; D K Burns; L Almasy; J Blangero; W T Garvey; P H Bennett; W C Knowler Journal: Am J Hum Genet Date: 1998-10 Impact factor: 11.025
Authors: Michèle M Sale; Barry I Freedman; Carl D Langefeld; Adrienne H Williams; Pamela J Hicks; Carla J Colicigno; Stephanie R Beck; W Mark Brown; Stephen S Rich; Donald W Bowden Journal: Diabetes Date: 2004-03 Impact factor: 9.461
Authors: Bao-Zhu Yang; Shizhong Han; Henry R Kranzler; Lindsay A Farrer; Joel Gelernter Journal: Neuropsychopharmacology Date: 2011-08-17 Impact factor: 7.853
Authors: Lei Cao; Rashin Sedighi; Ava Boston; Lakmini Premadasa; Jamilla Pinder; George E Crawford; Olugbemiga E Jegede; Scott H Harrison; Robert H Newman; Elimelda Moige Ongeri Journal: Int J Nephrol Date: 2018-04-29